Tri Chemical Laboratories Inc. provided consolidated earnings guidance for the fiscal year ending January 31, 2024. For the year, the company expects net sales of JPY 11,300 million, operating profit of JPY 1,700 million and profit attributable to owners of parent of JPY 2,680 million or JPY 82.47 per basic share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,310 JPY | +0.23% | -0.12% | +19.39% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.39% | 916M | |
+14.70% | 65.04B | |
-1.61% | 47.76B | |
+14.58% | 40.72B | |
+20.84% | 26.88B | |
+1.16% | 17.53B | |
-21.87% | 16.03B | |
+1.11% | 15.17B | |
-11.34% | 15.06B | |
-20.82% | 13.62B |
- Stock Market
- Equities
- 4369 Stock
- News Tri Chemical Laboratories Inc.
- Tri Chemical Laboratories Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending January 31, 2024